Company news: Johnson & Johnson's (JNJ) quarterly results top analysts’ estimates

Johnson & Johnson (JNJ) reported Q2 FY2024 earnings of $2.82 per share (versus $2.80 per share in Q2 FY2023), beating analysts’ consensus estimate of $2.71 per share.

The company’s quarterly revenues amounted to $22.447 bln (+4.3% y/y), beating analysts’ consensus estimate of $22.330 bln.

The company lowered FY2024 EPS guidance to $9.97-10.07 from $10.57-10.72 versus analysts’ consensus estimate of $10.45 and reaffirmed FY2024 revenues guidance of $88.0-88.4 bln versus analysts’ consensus estimate of $88.57 bln.

JNJ fell to $150.98 (-0.02%) in pre-market trading.